Big Data Development Pharma Companies 
Pharmaceutical Technology
JANUARY 16, 2023
The report also suggested that Big Data was thought to be the most important partner to AI, in terms of introducing technology-related changes in the pharmaceutical sector (Figure 2). In addition to collaborating with AI-technology providers, pharma companies are also engaging in vertical integration.
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
JANUARY 29, 2025
With machine learning and big data analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns. Big data analytics plays a crucial role in identifying prescribing patterns, understanding patient behaviors, and tailoring content strategies.
pharmaphorum
MARCH 19, 2021
The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,
Cloudbyz
SEPTEMBER 25, 2020
HEPAprint, MEDIKURA, Navro, Embleema & Cloudbyz develop 5 top solutions to watch out for. Our Innovation Analysts recently looked into emerging technologies and up-and-coming startups working on solutions for the pharma sector. Clinical trials play a pivotal role in drug development. HEPAprint – Adverse Drug Reaction (ADR).
Pharmaceutical Technology
NOVEMBER 9, 2022
According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. The legacy of this disruption has been a rethink in the way pharma companies do business.
pharmaphorum
FEBRUARY 11, 2022
Instead, Komodo’s software is the gateway to the Map’s data. One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. The business of data. Our software is deployed across two dimensions. About the author.
Expert insights. Personalized for you.
303 
Let's personalize your content